Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership705,793 shares
Latest Disclosed Value $ 68,638,420
Morgan Stanley reports 8.29% increase in ownership of RVMD / Revolution Medicines, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 705,793 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $68,638,420 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 651,732 shares of Revolution Medicines, Inc.. This represents a change in shares of 8.29% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 705,793 54,061 8.29 68,638 32.23 0.0041
2026-05-27 2025-12-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 651,732 -782,910 -54.57 51,911 -22.52 0.0031
2026-02-13 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 651,732 -782,910 51,911 0.0031
2026-05-27 2025-09-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 1,434,642 383,605 36.50 66,998 73.27 0.0041
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,434,642 383,605 66,998 0.0041
2025-08-15 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,051,037 -204,650 -16.30 38,668 -12.91 0.0025
2025-05-15 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 1,255,687 397,409 46.30 44,401 18.27 0.0032
2025-05-15 2024-12-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 858,278 205,460 31.47 37,541 26.81 0.0026
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 858,278 205,460 37,541 0.0026
2025-05-14 2024-09-30 13F/A-2 REVOLUTION MEDICINES COM 76155X100 652,818 -342,671 -34.42 29,605 -23.37 0.0021
2025-02-14 2024-09-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 652,818 -342,671 29,605 0.0021
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 652,818 -342,671 29,605 0.0003
2025-05-14 2024-06-30 13F/A-2 REVOLUTION MEDICINES COM 76155X100 995,489 68,419 7.38 38,635 29.30 0.0030
2024-10-17 2024-06-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 995,489 68,419 38,635 0.0030
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 995,489 68,419 38,635 0.0030
2024-10-17 2024-03-31 13F/A-2 REVOLUTION MEDICINES COM 76155X100 927,070 -726,104 -43.92 29,879 -36.98 0.0024
2024-08-16 2024-03-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 927,070 -726,104 29,879 0.0003
2024-05-15 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 927,070 -726,104 29,879 0.0024
2024-08-16 2023-12-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 1,653,174 851,201 106.14 47,413 113.59 0.0042
2024-02-13 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 1,653,174 851,201 47,413 0.0042
2023-11-15 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 801,973 -181,522 -18.46 22,199 -15.62 0.0023
2023-08-14 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 983,495 598,758 155.63 26,308 215.71 0.0026
2023-05-15 2023-03-31 13F REVOLUTION MEDICINES COM 76155X100 384,737 46,761 13.84 8,333 3.52 0.0009
2023-02-14 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 337,976 86,212 34.24 8,051 62.17 0.0009
2022-11-14 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 251,764 9,734 4.02 4,964 5.21 0.0007
2022-10-27 2022-06-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 242,030 54,261 28.90 4,718 -1.50 0.0006
2022-08-15 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 242,030 54,261 4,718 0.0001
2022-10-27 2022-03-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 187,769 138,843 283.78 4,790 289.11 0.0006
2022-05-13 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 187,769 138,843 4,790 0.0006
2022-02-14 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 48,926 -51,057 -51.07 1,231 -55.24 0.0002
2021-11-15 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 99,983 -426,435 -81.01 2,750 -83.54 0.0004
2021-08-23 2021-06-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 526,418 367,073 230.36 16,708 128.56 0.0022
2021-08-16 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 526,418 367,073 16,708 0.0005
2021-05-17 2021-03-31 13F REVOLUTION MEDICINES COM 76155X100 159,345 129,118 427.16 7,310 511.20 0.0011
2021-02-16 2020-12-31 13F REVOLUTION MEDICINES COM 76155X100 30,227 -21,957 -42.08 1,196 -34.14 0.0002
2020-11-13 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 52,184 22,431 75.39 1,816 93.40 0.0004
2020-08-14 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 29,753 -17,751 -37.37 939 -9.80 0.0002
2020-05-26 2020-03-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 47,504 47,504 1,041 0.0003
2020-05-15 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 47,504 1,041 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.